<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Anesth Essays Res</journal-id><journal-id journal-id-type="iso-abbrev">Anesth Essays Res</journal-id><journal-id journal-id-type="publisher-id">AER</journal-id><journal-title-group><journal-title>Anesthesia, Essays and Researches</journal-title></journal-title-group><issn pub-type="ppub">0259-1162</issn><issn pub-type="epub">2229-7685</issn><publisher><publisher-name>Medknow Publications &amp; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25885977</article-id><article-id pub-id-type="pmc">4173564</article-id><article-id pub-id-type="publisher-id">AER-7-326</article-id><article-id pub-id-type="doi">10.4103/0259-1162.123223</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Effect of nalbuphine and pentazocine on attenuation of hemodynamic changes during laryngoscopy and endotracheal intubation: A clinical study</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kothari</surname><given-names>Dilip</given-names></name><xref ref-type="aff" rid="aff1"></xref><xref ref-type="corresp" rid="cor1"></xref></contrib><contrib contrib-type="author"><name><surname>Sharma</surname><given-names>Chetan K.</given-names></name><xref ref-type="aff" rid="aff1"></xref></contrib></contrib-group><aff id="aff1">Department of Anesthesiology, G. R. Medical College, Gwalior, Madhya Pradesh, India</aff><author-notes><corresp id="cor1">
Corresponding Author: Dr. Dilip Kothari, 2-A, J. A. Hospital Campus, Lashkar, Gwalior, Madhya Pradesh, India. E-mail: <email xlink:href="drdilip-kothari@yahoo.co.in">drdilip-kothari@yahoo.co.in</email></corresp></author-notes><pub-date pub-type="ppub"><season>Sep-Dec</season><year>2013</year></pub-date><volume>7</volume><issue>3</issue><fpage>326</fpage><lpage>330</lpage><permissions><copyright-statement>Copyright: © Anesthesia: Essays and Researches</copyright-statement><copyright-year>2013</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec id="st1"><title><offsets xml_i="2712" xml_f="2723" txt_i="11" txt_f="22">Background:</offsets></title><p><offsets xml_i="2734" xml_f="3183" txt_i="23" txt_f="472">Narcotic drugs have been used to attenuate laryngoscopy and intubation induced circulatory responses, but are not always available due to tough narcotics laws. Nalbuphine a synthetic opioid, free from restrictions has been in use for post-operative pain relief. Hence, we decided to compare nalbuphine and pentazocine for attenuation of hemodynamic effects during larygoscopy and endotracheal intubation in a randomized, double-blind clinical study.</offsets></p></sec><sec id="st2"><title><offsets xml_i="3214" xml_f="3236" txt_i="474" txt_f="496">Materials and Methods:</offsets></title><p><offsets xml_i="3247" xml_f="3379" txt_i="497" txt_f="629">A total of 60 patients (ASA I and II) of either sex, between 18 years and 50 years were given either nalbuphine 0.2 mg/kg (group N, </offsets><italic><offsets xml_i="3387" xml_f="3388" txt_i="629" txt_f="630">n</offsets></italic><offsets xml_i="3397" xml_f="3439" txt_i="630" txt_f="672"> = 30) or pentazocine 0.5 mg/kg (group P, </offsets><italic><offsets xml_i="3447" xml_f="3448" txt_i="672" txt_f="673">n</offsets></italic><offsets xml_i="3457" xml_f="3634" txt_i="673" txt_f="850"> = 30) 5 min before induction of general anesthesia. After, induction with thiopentone and endotracheal intubation with succinylcholine balanced anesthesia was maintained with O</offsets><sub><offsets xml_i="3639" xml_f="3640" txt_i="850" txt_f="851">2</offsets></sub><offsets xml_i="3646" xml_f="3648" txt_i="851" txt_f="853">:N</offsets><sub><offsets xml_i="3653" xml_f="3654" txt_i="853" txt_f="854">2</offsets></sub><offsets xml_i="3660" xml_f="3924" txt_i="854" txt_f="1118">O, 0.2% halothane and non-depolarizing relaxants for surgical duration. Changes in heart rate (HR), systolic blood pressure (SBP), diastolic pressure, mean arterial pressure, and rate pressure product calculated by HR × SBP were recorded at various time intervals.</offsets></p></sec><sec id="st3"><title><offsets xml_i="3955" xml_f="3963" txt_i="1120" txt_f="1128">Results:</offsets></title><p><offsets xml_i="3974" xml_f="3998" txt_i="1129" txt_f="1153">A non-significant fall (</offsets><italic><offsets xml_i="4006" xml_f="4007" txt_i="1153" txt_f="1154">P</offsets></italic><offsets xml_i="4016" xml_f="4075" txt_i="1154" txt_f="1210"> &gt; 0.05) up to 3 min and thereafter a significant rise (</offsets><italic><offsets xml_i="4083" xml_f="4084" txt_i="1210" txt_f="1211">P</offsets></italic><offsets xml_i="4093" xml_f="4234" txt_i="1211" txt_f="1349"> &lt; 0.05) in all the parameters were observed throughout the remaining study period with nalbuphine, whereas a continuous and significant (</offsets><italic><offsets xml_i="4242" xml_f="4243" txt_i="1349" txt_f="1350">P</offsets></italic><offsets xml_i="4252" xml_f="4562" txt_i="1350" txt_f="1654"> &lt; 0.05) rise in these parameters were observed with pentazocine. Maximum rise in both the group was observed immediately after larygoscopy and intubation and these started to return toward the basal values at the end of the study period, but remained above the initial values. (pentazocine &gt; nalbuphine </offsets><italic><offsets xml_i="4570" xml_f="4571" txt_i="1654" txt_f="1655">P</offsets></italic><offsets xml_i="4580" xml_f="4593" txt_i="1655" txt_f="1665"> = &lt;0.01).</offsets></p></sec><sec id="st4"><title><offsets xml_i="4624" xml_f="4635" txt_i="1667" txt_f="1678">Conclusion:</offsets></title><p><offsets xml_i="4646" xml_f="4786" txt_i="1679" txt_f="1819">Nalbuphine effectively reduces the tachycardia, hypertension, and cardiac workload associated with laryngoscopy and endotracheal intubation.</offsets></p></sec></abstract><kwd-group><kwd>Endotracheal intubation</kwd><kwd>laryngoscopy</kwd><kwd>nalbuphine</kwd><kwd>pentazocine</kwd><kwd>rate pressure product</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title><offsets xml_i="5032" xml_f="5044" txt_i="1828" txt_f="1840">INTRODUCTION</offsets></title><p><offsets xml_i="5055" xml_f="5573" txt_i="1841" txt_f="2359">Hemodynamic changes due to stress responses caused by laryngoscopy and intubation are variable, transient and well-tolerated in American Society of Anesthesiologist I and II patients, but are of great concern for anesthesiologist especially in patients with pre-existing hypertension, myocardial ischemia, and cerebral pathologies with raised intracranial pressure as sudden rise in the heart rate (HR) and the blood pressure (BP) may cause high incidence of arrhythmias, myocardial ischemia, and cerebral hemorrhage.[</offsets><xref rid="ref1" ref-type="bibr"><offsets xml_i="5606" xml_f="5607" txt_i="2359" txt_f="2360">1</offsets></xref><xref rid="ref2" ref-type="bibr"><offsets xml_i="5647" xml_f="5648" txt_i="2360" txt_f="2361">2</offsets></xref><offsets xml_i="5655" xml_f="5656" txt_i="2361" txt_f="2362">]</offsets></p><p><offsets xml_i="5663" xml_f="5727" txt_i="2363" txt_f="2427">Numerous drugs including topical and/or intravenous lignocaine,[</offsets><xref rid="ref3" ref-type="bibr"><offsets xml_i="5760" xml_f="5761" txt_i="2427" txt_f="2428">3</offsets></xref><xref rid="ref4" ref-type="bibr"><offsets xml_i="5801" xml_f="5802" txt_i="2428" txt_f="2429">4</offsets></xref><offsets xml_i="5809" xml_f="5839" txt_i="2429" txt_f="2459">] short acting beta blockers,[</offsets><xref rid="ref5" ref-type="bibr"><offsets xml_i="5872" xml_f="5873" txt_i="2459" txt_f="2460">5</offsets></xref><offsets xml_i="5880" xml_f="5884" txt_i="2460" txt_f="2464">] Ca</offsets><sup><offsets xml_i="5889" xml_f="5891" txt_i="2464" txt_f="2466">++</offsets></sup><offsets xml_i="5897" xml_f="5916" txt_i="2466" txt_f="2485"> channel blockers,[</offsets><xref rid="ref6" ref-type="bibr"><offsets xml_i="5949" xml_f="5950" txt_i="2485" txt_f="2486">6</offsets></xref><offsets xml_i="5957" xml_f="5973" txt_i="2486" txt_f="2502">] vasodilators,[</offsets><xref rid="ref7" ref-type="bibr"><offsets xml_i="6006" xml_f="6007" txt_i="2502" txt_f="2503">7</offsets></xref><xref rid="ref8" ref-type="bibr"><offsets xml_i="6047" xml_f="6048" txt_i="2503" txt_f="2504">8</offsets></xref><offsets xml_i="6055" xml_f="6077" txt_i="2504" txt_f="2526">] magnesium sulphate,[</offsets><xref rid="ref9" ref-type="bibr"><offsets xml_i="6110" xml_f="6111" txt_i="2526" txt_f="2527">9</offsets></xref><offsets xml_i="6118" xml_f="6121" txt_i="2527" txt_f="2530">] α</offsets><sub><offsets xml_i="6126" xml_f="6127" txt_i="2530" txt_f="2531">2</offsets></sub><offsets xml_i="6133" xml_f="6144" txt_i="2531" txt_f="2542">-agonists,[</offsets><xref rid="ref10" ref-type="bibr"><offsets xml_i="6178" xml_f="6180" txt_i="2542" txt_f="2544">10</offsets></xref><xref rid="ref11" ref-type="bibr"><offsets xml_i="6221" xml_f="6223" txt_i="2544" txt_f="2546">11</offsets></xref><offsets xml_i="6230" xml_f="6250" txt_i="2546" txt_f="2566">] and opiates drugs[</offsets><xref rid="ref12" ref-type="bibr"><offsets xml_i="6284" xml_f="6286" txt_i="2566" txt_f="2568">12</offsets></xref><xref rid="ref13" ref-type="bibr"><offsets xml_i="6327" xml_f="6329" txt_i="2568" txt_f="2570">13</offsets></xref><xref rid="ref14" ref-type="bibr"><offsets xml_i="6370" xml_f="6372" txt_i="2570" txt_f="2572">14</offsets></xref><offsets xml_i="6379" xml_f="7062" txt_i="2572" txt_f="3255">] have been used to attenuate these responses. Opiate like fentanyl not only produces intense analgesia, but effectively attenuates these cardiovascular responses to stress, but associated problems such as post-operative nausea and vomiting, respiratory depression and unavailability owing to tough narcotic laws make its use difficult in routine. Pentazocine, a synthetically prepared prototypical mixed agonist-antagonist narcotic (opioid analgesic) drug of the benzomorphan class of opioids is widely used in perioperative period as this is free from narcotic laws, but hypertension and tachycardia limits it use during anesthesia, especially in hypertensive and cardiac patients.</offsets></p><p><offsets xml_i="7069" xml_f="7579" txt_i="3256" txt_f="3766">Recently, nalbuphine a synthetic opioid agonist-antagonist analgesic of the phenanthrene series free from tough narcotics laws is being marketed in India as peri-operative analgesic. This drug causes a reduction in HR and BP, but is sparingly evaluated for attenuation of stress responses during intubation. This has made us to evaluate and compare the effects of nalbuphine and pentazocine, on hemodynamic parameters during laryngoscopy and endotracheal intubation in a randomized double-blind clinical study.</offsets></p></sec><sec sec-type="materials|methods" id="sec1-2"><title><offsets xml_i="7642" xml_f="7663" txt_i="3768" txt_f="3789">MATERIALS AND METHODS</offsets></title><p><offsets xml_i="7674" xml_f="7990" txt_i="3790" txt_f="4106">After obtaining approval from Institutional Ethical Committee, and well-informed written consent, 60 patients (ASA grade I and II) of either sex and between the ages of 18 years and 50 years posted for various surgical procedures under general anesthesia were divided into two groups of small, fixed and equal size (</offsets><italic><offsets xml_i="7998" xml_f="7999" txt_i="4106" txt_f="4107">n</offsets></italic><offsets xml_i="8008" xml_f="8127" txt_i="4107" txt_f="4226"> = 30 each group) by simple random sampling or unrestricted sampling (lottery method) according to drugs used as below:</offsets></p><p><inline-graphic xlink:href="AER-7-326-g001.jpg"></inline-graphic></p><p><offsets xml_i="8206" xml_f="8361" txt_i="4228" txt_f="4383">Any patient with extreme of ages, major organ dysfunction, hypertension, myocardial ischemia, arrhythmias, cerebral pathology, and on medication such as Ca</offsets><sup><offsets xml_i="8366" xml_f="8368" txt_i="4383" txt_f="4385">++</offsets></sup><offsets xml_i="8374" xml_f="8455" txt_i="4385" txt_f="4466"> channel blocker, hypnotic or narcotic analgesic were not included in this study.</offsets></p><p><offsets xml_i="8462" xml_f="8962" txt_i="4467" txt_f="4967">All patients received an uniform premedication with Inj. glycopyrrolate 0.2 mg I.M., 30 min before the start of anesthesia. Upon arrival in operative room, baseline HR, systolic blood pressure (SBP), diastolic blood pressure (DBP), mean blood pressure (MAP) were recorded by non invasive blood pressure automatic apparatus (model infinity vista by Drager) thrice at an interval of 1 min and mean of these three values were recorded as basal value. Other monitoring including Electrocardiogram and SpO</offsets><sub><offsets xml_i="8967" xml_f="8968" txt_i="4967" txt_f="4968">2</offsets></sub><offsets xml_i="8974" xml_f="9448" txt_i="4968" txt_f="5442"> were also recorded to observe any complications. After securing an intravenous line the study drug was injected slowly over a period of 2 min by a resident doctor who was not involved in the study and did not know the contents of the syringe. After 3 min of pre-oxygenation, the general anesthesia was induced with thiopentone sodium 5 mg/kg followed by succinylcholine 1.5 mg/kg. Endotracheal intubation with appropriate size tube was done and lungs were ventilated with O</offsets><sub><offsets xml_i="9453" xml_f="9454" txt_i="5442" txt_f="5443">2</offsets></sub><offsets xml_i="9460" xml_f="9462" txt_i="5443" txt_f="5445">:N</offsets><sub><offsets xml_i="9467" xml_f="9468" txt_i="5445" txt_f="5446">2</offsets></sub><offsets xml_i="9474" xml_f="9793" txt_i="5446" txt_f="5765">O (33%:66%) and 0.2% halothane using Bain's circuit with a fresh gas flow of 110 ml/kg. Muscle relaxation was provided by Inj. vecuronium 0.08 mg/kg (loading dose) and 0.02 mg/kg (incremental doses). All the patients were reversed with Inj. glycopyrrolate 0.4 mg and Inj. Neostigmine 2.5 mg at the end of the procedure.</offsets></p><p><offsets xml_i="9800" xml_f="10359" txt_i="5766" txt_f="6325">HR, SBP, DBP, and MAP were recorded at 0 min (basal value), 1, 3, 5 min after the study drug, immediately after intubation and again at 1, 3, 5 min after the intubation. Rate pressure product (RPP) was calculated by formula: HR × SBP. Our study was terminated at 5 min after intubation, but all vitals were monitored throughout the anesthesia period as compulsory monitoring schedule. The observations recorded in both groups were tabulated and statistical analysis carried out by using appropriate statistical software (Epi Calc 2000 v1.02 version). Student </offsets><italic><offsets xml_i="10367" xml_f="10368" txt_i="6325" txt_f="6326">t</offsets></italic><offsets xml_i="10377" xml_f="10430" txt_i="6326" txt_f="6379"> test was used for intra and inter group comparison. </offsets><italic><offsets xml_i="10438" xml_f="10439" txt_i="6379" txt_f="6380">P</offsets></italic><offsets xml_i="10448" xml_f="10504" txt_i="6380" txt_f="6433"> &gt; 0.05 was taken to be statistically insignificant, </offsets><italic><offsets xml_i="10512" xml_f="10513" txt_i="6433" txt_f="6434">P</offsets></italic><offsets xml_i="10522" xml_f="10569" txt_i="6434" txt_f="6478"> &lt; 0.05 taken statistically significant and </offsets><italic><offsets xml_i="10577" xml_f="10578" txt_i="6478" txt_f="6479">P</offsets></italic><offsets xml_i="10587" xml_f="10643" txt_i="6479" txt_f="6532"> &lt; 0.01 taken to be statistically highly significant.</offsets></p></sec><sec sec-type="results" id="sec1-3"><title><offsets xml_i="10696" xml_f="10703" txt_i="6534" txt_f="6541">RESULTS</offsets></title><p><offsets xml_i="10714" xml_f="10770" txt_i="6542" txt_f="6598">Both groups were comparable for their demographic data [</offsets><xref ref-type="table" rid="T1"><offsets xml_i="10802" xml_f="10809" txt_i="6598" txt_f="6605">Table 1</offsets></xref><offsets xml_i="10816" xml_f="10842" txt_i="6605" txt_f="6631">] and baseline variables [</offsets><xref ref-type="table" rid="T2"><offsets xml_i="10874" xml_f="10881" txt_i="6631" txt_f="6638">Table 2</offsets></xref><offsets xml_i="10888" xml_f="10890" txt_i="6638" txt_f="6640">].</offsets></p><table-wrap id="T1" position="float"><label><offsets xml_i="10938" xml_f="10945" txt_i="6641" txt_f="6648">Table 1</offsets></label><caption><p><offsets xml_i="10965" xml_f="10981" txt_i="6648" txt_f="6664">Demographic data</offsets></p></caption><graphic xlink:href="AER-7-326-g002"></graphic></table-wrap><table-wrap id="T2" position="float"><label><offsets xml_i="11099" xml_f="11106" txt_i="6665" txt_f="6672">Table 2</offsets></label><caption><p><offsets xml_i="11126" xml_f="11180" txt_i="6672" txt_f="6726">Statistical analysis of various hemodynamic parameters</offsets></p></caption><graphic xlink:href="AER-7-326-g003"></graphic></table-wrap><sec id="sec2-1"><title><offsets xml_i="11278" xml_f="11280" txt_i="6727" txt_f="6729">HR</offsets></title><p><offsets xml_i="11291" xml_f="11723" txt_i="6730" txt_f="7162">In group N, after an initial decrease in mean HR, clinically significant increase (+19.56%) was observed immediately after endotracheal intubation (IAETI). Thereafter, HR again started to decrease, but remained above the mean basal values. In contrast, a continuous increase in mean HR was observed maximum being at IAETI (+24.11%) in group P, which started to decrease thereafter but it, remained well above the mean basal values [</offsets><xref ref-type="table" rid="T2"><offsets xml_i="11755" xml_f="11762" txt_i="7162" txt_f="7169">Table 2</offsets></xref><offsets xml_i="11769" xml_f="11771" txt_i="7169" txt_f="7171">].</offsets></p><p><offsets xml_i="11778" xml_f="11851" txt_i="7172" txt_f="7245">On intergroup comparison these changes were statistically insignificant (</offsets><italic><offsets xml_i="11859" xml_f="11860" txt_i="7245" txt_f="7246">P</offsets></italic><offsets xml_i="11869" xml_f="11939" txt_i="7246" txt_f="7313"> &gt; 0.05) until IAETI, but became statistically highly significant (</offsets><italic><offsets xml_i="11947" xml_f="11948" txt_i="7313" txt_f="7314">P</offsets></italic><offsets xml_i="11957" xml_f="12006" txt_i="7314" txt_f="7360"> &lt; 0.01) towards the end of the study period [</offsets><xref ref-type="table" rid="T3"><offsets xml_i="12038" xml_f="12045" txt_i="7360" txt_f="7367">Table 3</offsets></xref><offsets xml_i="12052" xml_f="12054" txt_i="7367" txt_f="7369">].</offsets></p><table-wrap id="T3" position="float"><label><offsets xml_i="12102" xml_f="12109" txt_i="7370" txt_f="7377">Table 3</offsets></label><caption><p><offsets xml_i="12129" xml_f="12185" txt_i="7377" txt_f="7433">Inter-group comparison of various hemodynamic parameters</offsets></p></caption><graphic xlink:href="AER-7-326-g004"></graphic></table-wrap></sec><sec id="sec2-2"><title><offsets xml_i="12289" xml_f="12291" txt_i="7435" txt_f="7437">BP</offsets></title><p><offsets xml_i="12302" xml_f="12382" txt_i="7438" txt_f="7518">All the three parameters of BP namely SBP, DBP and MAP showed a similar pattern.</offsets></p><p><offsets xml_i="12389" xml_f="12837" txt_i="7519" txt_f="7967">In group N, mean values of BP after an initial decrease until 5 min after the study drug showed a clinically significant rise at IAETI (maximum) and until 3 min thereafter, but fell below the mean basal values at the end of the study period. In group P, a continuous increase from mean basal values of BP were recorded throughout the study period maximum being at IAETI and remained well above the mean basal values at the end of the study period [</offsets><xref ref-type="table" rid="T2"><offsets xml_i="12869" xml_f="12876" txt_i="7967" txt_f="7974">Table 2</offsets></xref><offsets xml_i="12883" xml_f="12885" txt_i="7974" txt_f="7976">].</offsets></p><p><offsets xml_i="12892" xml_f="12966" txt_i="7977" txt_f="8051">On intergroup comparison, these changes were statistically insignificant (</offsets><italic><offsets xml_i="12974" xml_f="12975" txt_i="8051" txt_f="8052">P</offsets></italic><offsets xml_i="12984" xml_f="13074" txt_i="8052" txt_f="8139"> &gt; 0.05) until 5 min after study drugs, but became highly statistically significant a (</offsets><italic><offsets xml_i="13082" xml_f="13083" txt_i="8139" txt_f="8140">P</offsets></italic><offsets xml_i="13092" xml_f="13144" txt_i="8140" txt_f="8189"> &lt; 0.01) at IAETI and statistically significant (</offsets><italic><offsets xml_i="13152" xml_f="13153" txt_i="8189" txt_f="8190">P</offsets></italic><offsets xml_i="13162" xml_f="13210" txt_i="8190" txt_f="8235"> &lt; 0.05) toward the end of the study period [</offsets><xref ref-type="table" rid="T3"><offsets xml_i="13242" xml_f="13249" txt_i="8235" txt_f="8242">Table 3</offsets></xref><offsets xml_i="13256" xml_f="13258" txt_i="8242" txt_f="8244">].</offsets></p></sec><sec id="sec2-3"><title><offsets xml_i="13292" xml_f="13295" txt_i="8246" txt_f="8249">RPP</offsets></title><p><offsets xml_i="13306" xml_f="13708" txt_i="8250" txt_f="8652">In group N, after an initial fall in mean RPP a clinically significant rise (+28.42%) was observed at IAETI which decreased to + 2.72% at the end of the study period. In group P, a continuous increase in the mean RPP above the basal value was observed throughout the study period maximum being at IAETI (+42.0%). Although mean RPP decreased thereafter, but remained well above the basal value (17.7%) [</offsets><xref ref-type="table" rid="T2"><offsets xml_i="13740" xml_f="13747" txt_i="8652" txt_f="8659">Table 2</offsets></xref><offsets xml_i="13754" xml_f="13756" txt_i="8659" txt_f="8661">].</offsets></p><p><offsets xml_i="13763" xml_f="13895" txt_i="8662" txt_f="8794">On intergroup comparison, except for the initial 1 min after the study drugs all the changes were statistically highly significant (</offsets><italic><offsets xml_i="13903" xml_f="13904" txt_i="8794" txt_f="8795">P</offsets></italic><offsets xml_i="13913" xml_f="13926" txt_i="8795" txt_f="8805"> &lt; 0.01) [</offsets><xref ref-type="table" rid="T3"><offsets xml_i="13958" xml_f="13965" txt_i="8805" txt_f="8812">Table 3</offsets></xref><offsets xml_i="13972" xml_f="13974" txt_i="8812" txt_f="8814">].</offsets></p></sec></sec><sec sec-type="discussion" id="sec1-4"><title><offsets xml_i="14036" xml_f="14046" txt_i="8817" txt_f="8827">DISCUSSION</offsets></title><p><offsets xml_i="14057" xml_f="14219" txt_i="8828" txt_f="8990">In this comparative study, we evaluated the changes in hemodynamic parameter after the injection of the study drugs, and laryngoscopy and endotracheal intubation.</offsets></p><p><offsets xml_i="14226" xml_f="14250" txt_i="8991" txt_f="9015">A non-significant fall (</offsets><italic><offsets xml_i="14258" xml_f="14259" txt_i="9015" txt_f="9016">P</offsets></italic><offsets xml_i="14268" xml_f="14450" txt_i="9016" txt_f="9195"> &gt; 0.05) in HR and all the three parameters of BP (SBP, DBP, MAP) till 3 min was observed with nalbuphine, which could be attributed to strong and predominant k agonistic action.[</offsets><xref rid="ref15" ref-type="bibr"><offsets xml_i="14484" xml_f="14486" txt_i="9195" txt_f="9197">15</offsets></xref><offsets xml_i="14493" xml_f="14522" txt_i="9197" txt_f="9226">] Further a non-significant (</offsets><italic><offsets xml_i="14530" xml_f="14531" txt_i="9226" txt_f="9227">P</offsets></italic><offsets xml_i="14540" xml_f="14795" txt_i="9227" txt_f="9479"> &gt; 0.05) rise in HR and fall in BP at 5 min of injection could be attributed to effect of thiopentone sodium used as an induction agent for general anesthesia, a drug very well known for producing hypotension and associated reflex induced tachycardia.[</offsets><xref rid="ref16" ref-type="bibr"><offsets xml_i="14829" xml_f="14831" txt_i="9479" txt_f="9481">16</offsets></xref><xref rid="ref17" ref-type="bibr"><offsets xml_i="14872" xml_f="14874" txt_i="9481" txt_f="9483">17</offsets></xref><offsets xml_i="14881" xml_f="14882" txt_i="9483" txt_f="9484">]</offsets></p><p><offsets xml_i="14889" xml_f="15176" txt_i="9485" txt_f="9772">Both the drugs could not abolish the tachycardia associated with laryngocopy and intubation. A clinically significant rise in HR was observed with pentazocine (+24.11%) as compared to nalbuphine (+19.56%), although these values were statistically insignificant on intergroup comparison (</offsets><italic><offsets xml_i="15184" xml_f="15185" txt_i="9772" txt_f="9773">P</offsets></italic><offsets xml_i="15194" xml_f="15248" txt_i="9773" txt_f="9824"> &gt; 0.05). A statistically highly significant rise (</offsets><italic><offsets xml_i="15256" xml_f="15257" txt_i="9824" txt_f="9825">P</offsets></italic><offsets xml_i="15266" xml_f="15467" txt_i="9825" txt_f="10023"> &lt; 0.01) from basal mean values in all the three parameters of BP was observed immediately after intubation in both groups, but clinically this rise was more apparent with pentazocine. Ahsan-ul-Haq </offsets><italic><offsets xml_i="15475" xml_f="15480" txt_i="10023" txt_f="10028">et al</offsets></italic><offsets xml_i="15489" xml_f="15491" txt_i="10028" txt_f="10030">.[</offsets><xref rid="ref18" ref-type="bibr"><offsets xml_i="15525" xml_f="15527" txt_i="10030" txt_f="10032">18</offsets></xref><offsets xml_i="15534" xml_f="15642" txt_i="10032" txt_f="10140">] reported an increase in HR (+15.5%) and MAP (+10.5%) with nalbuphine immediately after intubation. Adachi </offsets><italic><offsets xml_i="15650" xml_f="15655" txt_i="10140" txt_f="10145">et al</offsets></italic><offsets xml_i="15664" xml_f="15666" txt_i="10145" txt_f="10147">.[</offsets><xref rid="ref13" ref-type="bibr"><offsets xml_i="15700" xml_f="15702" txt_i="10147" txt_f="10149">13</offsets></xref><offsets xml_i="15709" xml_f="15805" txt_i="10149" txt_f="10245">] reported that pentazocine 0.5 mg/kg failed to diminish the circulatory response to intubation.</offsets></p><p><offsets xml_i="15812" xml_f="15912" txt_i="10246" txt_f="10346">RPP is a very sensitive index for myocardial work load and increased myocardial oxygen consumption.[</offsets><xref rid="ref19" ref-type="bibr"><offsets xml_i="15946" xml_f="15948" txt_i="10346" txt_f="10348">19</offsets></xref><offsets xml_i="15955" xml_f="16278" txt_i="10348" txt_f="10671">] In our study it is evident that nalbuphine is able to produce significant decrease in RPP as compared to pentazocine immediately after intubation (−28.42% and −42.0% respectively). Toward the end of the study period RPP returned very near to basal values in group N as against to group P (+2.12% and +17.7% respectively).</offsets></p><p><offsets xml_i="16285" xml_f="16375" txt_i="10672" txt_f="10762">Both the drugs used in our study are mixed opioid agonist antagonist. Nalbuphine binds to </offsets><italic><offsets xml_i="16383" xml_f="16384" txt_i="10762" txt_f="10763">μ</offsets></italic><offsets xml_i="16393" xml_f="16453" txt_i="10763" txt_f="10823">, κ, and δ opioid receptors, and is primarily κ agonist and </offsets><italic><offsets xml_i="16461" xml_f="16462" txt_i="10823" txt_f="10824">μ</offsets></italic><offsets xml_i="16471" xml_f="16484" txt_i="10824" txt_f="10837"> antagonist.[</offsets><xref rid="ref15" ref-type="bibr"><offsets xml_i="16518" xml_f="16520" txt_i="10837" txt_f="10839">15</offsets></xref><offsets xml_i="16527" xml_f="16741" txt_i="10839" txt_f="11053">] In group N, the initial fall in all the hemodynamic parameters is because of its strong and predominant κ agonistic action. Rise in hemodynamic parameters after intubation are due to sympathoadrenal stimulation.[</offsets><xref rid="ref20" ref-type="bibr"><offsets xml_i="16775" xml_f="16777" txt_i="11053" txt_f="11055">20</offsets></xref><offsets xml_i="16784" xml_f="16785" txt_i="11055" txt_f="11056">]</offsets></p><p><offsets xml_i="16792" xml_f="16831" txt_i="11057" txt_f="11096">Pentazocine is a partial κ agonist and </offsets><italic><offsets xml_i="16839" xml_f="16840" txt_i="11096" txt_f="11097">μ</offsets></italic><offsets xml_i="16849" xml_f="16861" txt_i="11097" txt_f="11109"> antagonist[</offsets><xref rid="ref21" ref-type="bibr"><offsets xml_i="16895" xml_f="16897" txt_i="11109" txt_f="11111">21</offsets></xref><offsets xml_i="16904" xml_f="17190" txt_i="11111" txt_f="11397">] and is known to cause an increase in arterial BP, HR, systemic vascular resistance and blood catecholamine levels while depressing the myocardial contractility and increasing the cardiac workload, which may be the cause of the steady rise in all the hemodynamic parameters in group P.</offsets></p></sec><sec sec-type="conclusion" id="sec1-5"><title><offsets xml_i="17246" xml_f="17256" txt_i="11399" txt_f="11409">CONCLUSION</offsets></title><p><offsets xml_i="17267" xml_f="17424" txt_i="11410" txt_f="11567">We conclude that nalbuphine effectively reduces the tachycardia, hypertension, and cardiac workload associated with laryngoscopy and endotracheal intubation.</offsets></p></sec></body><back><fn-group><fn fn-type="supported-by"><p><bold>Source of Support:</bold> Nil</p></fn><fn fn-type="conflict"><p><bold>Conflict of Interest:</bold> None declared.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edwards</surname><given-names>ND</given-names></name><name><surname>Alford</surname><given-names>AM</given-names></name><name><surname>Dobson</surname><given-names>PM</given-names></name><name><surname>Peacock</surname><given-names>JE</given-names></name><name><surname>Reilly</surname><given-names>CS</given-names></name></person-group><article-title>Myocardial ischaemia during tracheal intubation and extubation</article-title><source>Br J Anaesth</source><year>1994</year><volume>73</volume><fpage>537</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">7999498</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fox</surname><given-names>EJ</given-names></name><name><surname>Sklar</surname><given-names>GS</given-names></name><name><surname>Hill</surname><given-names>CH</given-names></name><name><surname>Villanueva</surname><given-names>R</given-names></name><name><surname>King</surname><given-names>BD</given-names></name></person-group><article-title>Complications related to the pressor response to endotracheal intubation</article-title><source>Anesthesiology</source><year>1977</year><volume>47</volume><fpage>524</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">337858</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gotta</surname><given-names>AW</given-names></name><name><surname>Sullivan</surname><given-names>CA</given-names></name></person-group><article-title>Anaesthesia of the upper airway using topical anaesthetic and superior laryngeal nerve block</article-title><source>Br J Anaesth</source><year>1981</year><volume>53</volume><fpage>1055</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">7295450</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abou-Madi</surname><given-names>MN</given-names></name><name><surname>Keszler</surname><given-names>H</given-names></name><name><surname>Yacoub</surname><given-names>JM</given-names></name></person-group><article-title>Cardiovascular reactions to laryngoscopy and tracheal intubation following small and large intravenous doses of lidocaine</article-title><source>Can Anaesth Soc J</source><year>1977</year><volume>24</volume><fpage>12</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">832175</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ebert</surname><given-names>TJ</given-names></name><name><surname>Bernstein</surname><given-names>JS</given-names></name><name><surname>Stowe</surname><given-names>DF</given-names></name><name><surname>Roerig</surname><given-names>D</given-names></name><name><surname>Kampine</surname><given-names>JP</given-names></name></person-group><article-title>Attenuation of hemodynamic responses to rapid sequence induction and intubation in healthy patients with a single bolus of esmolol</article-title><source>J Clin Anesth</source><year>1990</year><volume>2</volume><fpage>243</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">1975189</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yaku</surname><given-names>H</given-names></name><name><surname>Mikawa</surname><given-names>K</given-names></name><name><surname>Maekawa</surname><given-names>N</given-names></name><name><surname>Obara</surname><given-names>H</given-names></name></person-group><article-title>Effect of verapamil on the cardiovascular responses to tracheal intubation</article-title><source>Br J Anaesth</source><year>1992</year><volume>68</volume><fpage>85</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">1346745</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stoelting</surname><given-names>RK</given-names></name></person-group><article-title>Attenuation of blood pressure response to laryngoscopy and tracheal intubation with sodium nitroprusside</article-title><source>Anesth Analg</source><year>1979</year><volume>58</volume><fpage>116</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">571234</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mikawa</surname><given-names>K</given-names></name><name><surname>Hasegawa</surname><given-names>M</given-names></name><name><surname>Suzuki</surname><given-names>T</given-names></name><name><surname>Maekawa</surname><given-names>N</given-names></name><name><surname>Kaetsu</surname><given-names>H</given-names></name><name><surname>Goto</surname><given-names>R</given-names></name><etal></etal></person-group><article-title>Attenuation of hypertensive response to tracheal intubation with nitroglycerin</article-title><source>J Clin Anesth</source><year>1992</year><volume>4</volume><fpage>367</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">1389189</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kothari</surname><given-names>D</given-names></name><name><surname>Mehrotra</surname><given-names>A</given-names></name><name><surname>Choudhary</surname><given-names>B</given-names></name><name><surname>Mehra</surname><given-names>A</given-names></name></person-group><article-title>Effect of Intravenous magnesium sulfate and fentanyl citrate on circulatory changes during anaesthesia and surgery: A clinical study</article-title><source>Indian J Anaesth</source><year>2008</year><volume>52</volume><fpage>800</fpage><lpage>4</lpage></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kulka</surname><given-names>PJ</given-names></name><name><surname>Tryba</surname><given-names>M</given-names></name><name><surname>Zenz</surname><given-names>M</given-names></name></person-group><article-title>Dose-response effects of intravenous clonidine on stress response during induction of anesthesia in coronary artery bypass graft patients</article-title><source>Anesth Analg</source><year>1995</year><volume>80</volume><fpage>263</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">7818111</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheinin</surname><given-names>B</given-names></name><name><surname>Lindgren</surname><given-names>L</given-names></name><name><surname>Randell</surname><given-names>T</given-names></name><name><surname>Scheinin</surname><given-names>H</given-names></name><name><surname>Scheinin</surname><given-names>M</given-names></name></person-group><article-title>Dexmedetomidine attenuates sympathoadrenal responses to tracheal intubation and reduces the need for thiopentone and peroperative fentanyl</article-title><source>Br J Anaesth</source><year>1992</year><volume>68</volume><fpage>126</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">1347229</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van den Berg</surname><given-names>AA</given-names></name><name><surname>Halliday</surname><given-names>EM</given-names></name><name><surname>Soomro</surname><given-names>NA</given-names></name><name><surname>Rasheed</surname><given-names>A</given-names></name><name><surname>Baloch</surname><given-names>M</given-names></name></person-group><article-title>Reducing cardiovascular responses to laryngoscopy and tracheal intubation: A comparison of equipotent doses of tramadol, nalbuphine and pethidine, with placebo</article-title><source>Middle East J Anesthesiol</source><year>2004</year><volume>17</volume><fpage>1023</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">15651510</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adachi</surname><given-names>Y</given-names></name><name><surname>Takamatsu</surname><given-names>I</given-names></name><name><surname>Harada</surname><given-names>M</given-names></name><name><surname>Uchihashi</surname><given-names>Y</given-names></name><name><surname>Karasawa</surname><given-names>F</given-names></name><name><surname>Sato</surname><given-names>T</given-names></name><etal></etal></person-group><article-title>The effects of low-doses of fentanyl, buprenorphine and pentazocine on circulatory responses to endotracheal intubation</article-title><source>Masui</source><year>1998</year><volume>47</volume><fpage>1478</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">9990217</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kay</surname><given-names>B</given-names></name><name><surname>Healy</surname><given-names>TE</given-names></name><name><surname>Bolder</surname><given-names>PM</given-names></name></person-group><article-title>Blocking the circulatory responses to tracheal intubation. A comparison of fentanyl and nalbuphine</article-title><source>Anaesthesia</source><year>1985</year><volume>40</volume><fpage>960</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">4061801</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Opoids</surname><given-names>FK</given-names></name></person-group><article-title>Nalbuphine. Miller's Anaesthesia</article-title><year>2010</year><edition>7th ed</edition><publisher-loc>Philadelphia PA</publisher-loc><publisher-name>Churchill Livingstone, Elsevier</publisher-name><fpage>809</fpage></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Todd</surname><given-names>MM</given-names></name><name><surname>Drummond</surname><given-names>JC</given-names></name><name><surname>U</surname><given-names>HS</given-names></name></person-group><article-title>The hemodynamic consequences of high-dose thiopental anesthesia</article-title><source>Anesth Analg</source><year>1985</year><volume>64</volume><fpage>681</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">4014729</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kissin</surname><given-names>I</given-names></name><name><surname>Motomura</surname><given-names>S</given-names></name><name><surname>Aultman</surname><given-names>DF</given-names></name><name><surname>Reves</surname><given-names>JG</given-names></name></person-group><article-title>Inotropic and anesthetic potencies of etomidate and thiopental in dogs</article-title><source>Anesth Analg</source><year>1983</year><volume>62</volume><fpage>961</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">6625216</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahsan-ul-Haq</surname><given-names>M</given-names></name><name><surname>Kazmi</surname><given-names>EH</given-names></name><name><surname>Rao</surname><given-names>ZA</given-names></name></person-group><article-title>Nalbuphine prevents haemodynamic response to endotracheal intubation</article-title><source>J Coll Physicians Surg Pak</source><year>2005</year><volume>15</volume><fpage>668</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">16300696</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagpal</surname><given-names>S</given-names></name><name><surname>Walia</surname><given-names>L</given-names></name><name><surname>Lata</surname><given-names>H</given-names></name><name><surname>Sood</surname><given-names>N</given-names></name><name><surname>Ahuja</surname><given-names>GK</given-names></name></person-group><article-title>Effect of exercise on rate pressure product in premenopausal and postmenopausal women with coronary artery disease</article-title><source>Indian J Physiol Pharmacol</source><year>2007</year><volume>51</volume><fpage>279</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">18341225</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>M</given-names></name></person-group><article-title>Stress response and Anaesthesia, Altering the peri and post-operative management</article-title><source>Indian J Anaesth</source><year>2003</year><volume>47</volume><fpage>427</fpage><lpage>34</lpage></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Opoids</surname><given-names>FK</given-names></name></person-group><article-title>Pentazocine. Miller's Anaesthesia</article-title><year>2010</year><edition>7th ed</edition><publisher-loc>Philadelphia PA</publisher-loc><publisher-name>Churchill Livingstone, Elsevier</publisher-name><fpage>808</fpage></element-citation></ref></ref-list></back></article>